MedPath

To evaluate whether Yoga can delay initiation of Insulin in patients with type 2 diabetes mellitus

Not yet recruiting
Conditions
1.Patients with Type 2 diabetes mellitus2.HbA1c less than or equal to 8%3.On Oral drugs for diabetes with patient taking at least 2 drugs
Registration Number
CTRI/2017/04/008370
Lead Sponsor
ICMR
Brief Summary

The2015 update of the IDF (International Diabetes Federation) Atlas estimatesaround 69.2 million people in India to be affected by diabetes [1]. As per theUnited Kingdom Prospective Diabetes Study, 50% of pancreatic beta cells arealready lost at the time of diagnosis, with a subsequent decline of 3-5% peryear [2]. Hence, most people with type 2 diabetes (T2DM) ultimately requireinsulin therapy because of the progressive nature of their disease. Thedifficulty encountered in clinical practice relates to the acceptance ofswitching over to insulin when oral hypoglycemic agents have failed. Althoughfactors like inaccessibility (lack of personal resources) and inconveniencerelated to injection and timing of meals play an important role, ‘psychologicalresistance’ due to executive and emotional dysfunction remains an important yetignored factor [3]. Yoga is a mind/body practicebased on traditional Indian philosophy, often incorporating four majorcomponents: physical postures, breathing exercises, meditation and relaxation. Studiescomparing yoga to metabolically matched walking have shown a greaterimprovement in mood, greater decrease in anxiety and increase in levels ofthalamic gamma amino butyric acid (on brain magnetic resonance spectroscopy) inyoga asana practitioners [4]. In a systematic review on 25 randomizedcontrolled trials on 2170 participants, yoga was found to improve glycemiccontrol, lipid levels, oxidative stress, blood pressure and pulmonary andautonomic function. In addition, there was a reduced need for medication andimproved mood and sleep [5]. Hence, it would be worth studying the effect ofyoga (over and above the use of 2/3 oral hypoglycemic agents) in improvingglycemic and metabolic control, and see if a systematic yoga protocol can delayinsulin initiation in these patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Age > 30 years < 70 years 2.
  • Willing to adhere to protocol (Intervention, follow up, investigations, drug escalation as per protocol) 3.
  • Not on Insulin 4.
  • HbA1C more than or equal to 6.5 % to less than or equal to 8 5.
  • On Oral drugs for diabetes with patient taking at least 2 drugs in maximal or near maximal dose as per protocol, regularly for 3 months 6.
  • No physical limitation for doing Yoga for 45 minutes a day.
  • Willing to do Yoga or walking at least 5 days a week.
  • Willing to come for Yoga classes (13 classes in 4 months) at AIIMS.
Exclusion Criteria

1.Terminal illness 2.Known case of cancer 3.Nephropathy with CKD stage 4 and 5 4.Severe Non proliferative diabetic retinopathy, proliferative diabetic retinopathy, or macular edema 5.Any cardiovascular event requiring hospitalization in last 6 months 6.Active diabetic foot ulcer 7.Hospitalization for more than 24 hours within one month or 2 such episodes in last 6 months 8.PHQ-9 score > 14 9.Presence of suicidal thoughts for question 9 of PHQ-9 questionnaire.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2. HbA1c less than or equal to 8.0% at 8 months4, 8 and 12 months
Time to event4, 8 and 12 months
1. HbA1c less than or equal to 8.5% at 4 months4, 8 and 12 months
3. HbA1c less than or equal to 7.5 % at 12 months4, 8 and 12 months
4. Increase of HbA1c by 1% as compared to baseline at any point of evaluation4, 8 and 12 months
Secondary Outcome Measures
NameTimeMethod
Metabolic parameters: Weight and waist circumference4,8,12 months
Psychological parameters: Depression4 and 12 months
Cognitive functioning12 months
Economic benefits4 and 12 months
Problem Areas in Diabetes Score4 and 12 months
Qualitative interview of participants receiving Yoga therapyAt end of study. 3rd Year of study

Trial Locations

Locations (2)

All India Institute of Medical Sciences, Delhi

🇮🇳

South, DELHI, India

Madras Diabetes Research Foundation

🇮🇳

Chennai, TAMIL NADU, India

All India Institute of Medical Sciences, Delhi
🇮🇳South, DELHI, India
Dr Yashdeep Gupta
Principal investigator
01126593237
yash_deep_gupta@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.